Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Depreciation & Amortization (CF) (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Depreciation & Amortization (CF) for 3 consecutive years, with $666000.0 as the latest value for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 8.47% year-over-year to $666000.0; the TTM value through Dec 2025 reached $2.6 million, up 6.83%, while the annual FY2025 figure was $2.6 million, 6.83% up from the prior year.
  • Depreciation & Amortization (CF) hit $666000.0 in Q4 2025 for Artiva Biotherapeutics, up from $662000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $666000.0 in Q4 2025 and bottomed at $500000.0 in Q2 2023.
  • Average Depreciation & Amortization (CF) over 3 years is $607090.9, with a median of $614000.0 recorded in 2024.
  • On a YoY basis, Depreciation & Amortization (CF) climbed as much as 20.6% in 2024 and fell as far as 3.37% in 2024.
  • Artiva Biotherapeutics' Depreciation & Amortization (CF) stood at $594000.0 in 2023, then rose by 3.37% to $614000.0 in 2024, then rose by 8.47% to $666000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $666000.0, $662000.0, and $641000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.